Geoffrey Michael Glass - Jun 1, 2022 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
Stock symbol
AVDL
Transactions as of
Jun 1, 2022
Transactions value $
$96,300
Form type
4
Date filed
6/2/2022, 04:02 PM
Previous filing
Jun 3, 2022
Next filing
Aug 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVDL ADSs Purchase $96.3K +45K $2.14 45K Jun 1, 2022 By Trust F1, F2, F3
holding AVDL ADSs 65.7K Jun 1, 2022 By Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 These ADSs are held by The Geoffrey Glass Trust of which the reporting person is a co-trustee. The reporting person is the sole beneficiary of the trust.
F4 These ADSs are held by Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 of which the reporting person is trustee. The reporting person and members of his immediate family are the sole beneficiaries of the trust.